XenoTherapeutics
Business Services · Massachusetts, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
PO Box 130112, Boston, Massachusetts, 02...Phone Number
(617) 939-7892Website
www.xenotherapeutics.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About XenoTherapeutics
XenoTherapeutics Foundation is a not-for-profit research organization focused on advancing regenerative medicine through xenotransplantation. They utilize genetically engineered pigs as a reliable source for tissue donation, aiming to improve the accessibility and effectiveness of regenerative therapies. Their initial product, realSKIN, is a living skin transplant designed to aid healing after severe injuries. The foundation collaborates with academic institutions to explore new applications for their innovative therapies.Explore more
XenoTherapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is XenoTherapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
XenoTherapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when XenoTherapeutics launches new products
Congratulate Masked Content for being promoted to Masked Content at XenoTherapeutics
Check out if XenoTherapeutics is spiking on competitors!
Funding: Get notified immidiatlly once XenoTherapeutics has new funding data
Check if XenoTherapeutics has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Click to see if XenoTherapeutics had a recent Job posting/layoffs
Earning: See what the market has to say on XenoTherapeutics recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Find VP level buyers at XenoTherapeutics
Find 2 more new buyers
Compare Similar Companies to XenoTherapeutics
Compare insights from companies similar to XenoTherapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
XenoTherapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
XenoTherapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about XenoTherapeutics.
XenoTherapeutics Tech Stack
A closer look at the technologies used by XenoTherapeutics
XenoTherapeutics News & Media
ESSA Announces Completion of Arrangement with XenoTherapeutics
SOUTH SAN FRANCISCO, Calif., USA and VANCOUVER, BC, Canada, Oct. 9, 2025 /PRNewswire/ - ESSA Pharma Inc. (NASDAQ: EPIX) ("ESSA" or the "Company") today announced the completion of XenoTherapeutics' ("Xeno") previously announced acquisition of ESSA (the "Acquisition"). Xeno Acquisition...ESSA Securityholders Approve Acquisition by XenoTherapeutics
SOUTH SAN FRANCISCO, USA and VANCOUVER, Canada, Oct. 6, 2025 /PRNewswire/ - ESSA Pharma Inc. (NASDAQ: EPIX) ("ESSA" or the "Company") is pleased to announce that its Securityholders (as defined below) have approved the acquisition of all of the issued and outstanding common shares of the...ESSA Pharma Inc. Provides Update on its Application to the Supreme Court of British Columbia for Amended Interim Order
SOUTH SAN FRANCISCO, Calif. and VANCOUVER, BC, Sept. 30, 2025 /PRNewswire/ -- ESSA Pharma Inc. ("ESSA," or the "Company") (NASDAQ: EPIX) today announced that, in connection with its previously announced Business Combination Agreement with XenoTherapeutics Inc. ("Xeno"), a non-profit...ESSA Pharma Inc. Amends Agreement with XenoTherapeutics
Shareholders expected to receive approximately $0.12 per share in cash upon closing of transaction and up to approximately $0.14 per CVR under revised terms Further Adjourns Special Meeting to October 3, 2025 SOUTH SAN FRANCISCO, Calif. and VANCOUVER, BC, Sept. 24, 2025 /PRNewswire/ --...
Read more news
Top Business Services Companies
See more top companies
Frequently Asked Questions Regarding XenoTherapeutics
Sign Up For FreeTo access detailed company insights
XenoTherapeutics Foundation is a not-for-profit research organization focused on advancing regenerative medicine through xenotransplantation. They utilize genetically engineered pigs as a reliable source for tissue donation, aiming to improve the accessibility and effectiveness of regenerative therapies. Their initial product, realSKIN, is a living... Read More
